Iris Nagtegaal

Professor of Gastrointestinal Pathology

Radboudumc

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Cancer Biology Cancer Biology professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Iris Nagtegaal is a Professor of Gastrointestinal Pathology at Radboudumc in the Netherlands. Her research primarily focuses on colorectal cancer, exploring areas such as tumor biology, the immunological landscape of tumors, and the genetic features of digestive system tumors. Recent publications include studies on growth rate alterations of colorectal cancer cells, the Consensus Immunoscore for chemotherapy response prediction, and the role of tumor budding in various cancers.

Articles (10)

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (3)

Marien de Jonge

Head of the Laboratory of Medical Immunology

Radboud University Medical Center

NETHERLANDS

View details

Julia Y. Wang

Chief Scientific Officer

UNITED STATES

View details

Manuel Salto-Tellez

Professor of Integrated Pathology

Institute of Cancer Research

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Iris Nagtegaal

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Growth rate alterations of human colorectal cancer cells by 157 gut bacteria.

Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer.

Tumour budding in solid cancers.

COLONOSCOPY-RELATED MORTALITY IN A FECAL IMMUNOCHEMICAL TEST-BASED COLORECTAL CANCER SCREENING PROGRAM.

Medullary Pancreatic Carcinoma Due to Somatic POLE Mutation: A Distinctive Pancreatic Carcinoma With Marked Long-Term Survival.

Diagnosis of Digestive System Tumours.

Clinical, Pathology, Genetic, and Molecular Features of Colorectal Tumors in Adolescents and Adults 25 Years or Younger.

Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition.

Are tumour grade and tumour budding equivalent in colorectal cancer? A retrospective analysis of 771 patients

Assessment of individual tumor buds using keratin immunohistochemistry: moderate interobserver agreement suggests a role for machine learning

Collaborators (3)

Marien de Jonge

Julia Y. Wang

Manuel Salto-Tellez

Make your next move.